Marc's practice focuses on patent law, both in advisory and litigation matters, related competition law issues as well as other intellectual property rights (trademark law, copyright law, design law).
Before joining Schertenleib Avocats, Marc worked as a lawyer in a European IP boutique and in the IP/IT department of an international law firm.
Marc was also Law Clerk for the intellectual property judges (3rd civil chamber) of Lyon Court of First Instance. This experience allowed him to prepare more than 50 IP cases for the judges, to attend hearings and deliberations, and to draft decisions.
He completed internships in various intellectual property departments of French and international law firms as well as in the European IP and civil litigation department of the leading international group in the luxury goods market.
Marc is fluent in French and in English.
Education
Master II Intellectual Property Law, Jean Moulin Lyon III University
Master I Business Law, Jean Moulin Lyon III University
License degree in Private Law, Jean Moulin Lyon III University
License degree in life sciences, University of Aix-Marseille
(ongoing)
Affiliation
AIPPI - Member of the UPC Standing Committee, LES, APEB
What others say
Next Generation Partner, Legal 500
Best lawyers : Ones to Watch
Publications
Contributor for France, France, Enforcement of Unified Patent Jurisdiction Decisions, Wolters Kluwer
National rapporteur in 2018 and 2019 for question B, relating to intellectual property issues, of the LIDC Congress published by Éditions Springer
Significant public cases
-
Represented an subsea test operator before the Paris Local Division of the Unified Patent Jurisdiction in seizure and infringement proceedings (first seizure decision handed down by the Paris Local Division)
-
Represented a generic company in patent infringement litigation relating to an S1P1 inhibitor used in the treatment of relapsing-remitting multiple sclerosis
-
Represented three generic companies in three infringement proceedings relating to an aryl urea compound used in the treatment of liver and kidney cancer
-
Represented a generic laboratory in patent litigation relating to an insulin glargine injection device
-
Represented a major player in aesthetic medicine in a dispute over know-how (claim for more than 150 million euros) and two patents relating to a process for manufacturing hyaluronic acid fillers
-
Represented a major retailer in a patent infringement dispute relating to laminates incorporated in diapers
-
Represented a manufacturer of hydroalcoholic and professional cleaning solutions in proceedings to revoke a 145 CPC order relating to alleged misappropriation of know-how
-
Represented a major global telephone manufacturer in patent infringement litigation relating to a presentation of information*
-
Represented an originator in a patent infringement action relating to a monoclonal antibody used in the treatment of diabetes*.
-
Represented an originator in a patent infringement action relating to a monoclonal antibody used in the treatment of psoriasis*.
-
Represented a major global toy manufacturer in patent infringement litigation for a sealing device*.
-
Represented an originator in a patent infringement action relating to a statin*.
* prior to Schertenleib Avocats